The analgesic efficacy and safety of transversus abdominis plane (TAP) block with levobupivacaine in abdominal surgery under general anesthesia

The analgesic efficacy and safety of transversus abdominis plane (TAP) block with levobupivacaine in abdominal surgery under general anesthesia - The analgesic efficacy and safety of transversus abdominis plane (TAP) block with levobupivacaine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003598

Enrollment

Registered

2010-06-21

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal diseases

Interventions

The TAP blocks with levobupivacaine are performed to the patients scheduled for abdominal surgery under general anesthesia. The TAP blocks with levobupivacaine are not performed.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA Physical status I-III patients scheduled for abdominal surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Severe renal and liver dysfunction A history of relevant drug allergy Medical therapies considered to result in tolerance to opiates Epidural anesthesia

Design outcomes

Primary

Measure	Time frame
We measure blood concentrations of levobupivacaine for evaluating the safety.	—

Secondary

Measure	Time frame
We record the pain score (visual analog scale) and postoperative analgesic requirements for evaluating the analgesic efficacy of TAP block with levobupivacaine	—

Countries

Japan

Contacts

Public ContactSatoshi Tanaka

Shinshu University school of medicine Dept. Anesthesiology and Resuscitology

s_tanaka@shinshu-u.ac.jp0263-37-2670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026